Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02092883 · ClinicalTrials.gov registry record · Phase 4
Evaluation of Neuroinflammation in Children With Infantile Spasms
A Phase 4 study, sponsored by Wayne State University.
- Completed
- Registry status
- Phase 4
- Development phase
- 8
- Enrollment target
NCT02092883 is a Phase 4 study that has completed, run by Wayne State University. The registered enrollment target is 8 participants.
The verdict
NCT02092883, a Phase 4 study, has completed, sponsored by Wayne State University.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 8 participants
- Enrollment target
Study Summary
The purpose of this study was to investigate the presence of neuroinflammation in children with infantile spasms using 11C-PK11195 positron emission tomography (PK PET) scan, and its response to ACTH treatment by repeating the PK PET scan after treatment.
Interventions
- DRUG ACTH
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2013-03 |
| Est. Completion | 2017-07 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02092883
The ClinicalTrials.gov registry entry for NCT02092883 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Wayne State University, which has 163 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which ACTH is the first listed.
NCT02092883 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02092883 about?
NCT02092883 is a clinical study titled "Evaluation of Neuroinflammation in Children With Infantile Spasms". The purpose of this study was to investigate the presence of neuroinflammation in children with infantile spasms using 11C-PK11195 positron emission tomography (PK PET) scan, and its response to ACTH treatment by repeating the PK PET scan after treatment.
What is the current status of trial NCT02092883?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 8 participants. The study started on 2013-03. Estimated completion is 2017-07.
What interventions are being tested in trial NCT02092883?
The interventions under investigation include: ACTH (DRUG).
Who is sponsoring clinical trial NCT02092883?
This trial is sponsored by Wayne State University, which has 163 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.